Propranolol: Clinical Trials

54 trials of Propranolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 13 unknown, 9 terminated, 3 not yet recruiting. 54 Phase 3, 21 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 354Completed 22, Unknown 13, Terminated 9, Not yet recruiting 3, Recruiting 3, Withdrawn 3, Active not recruiting 1
Phase 221Completed 9, Terminated 5, Unknown 4, Withdrawn 2, Active not recruiting 1

Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol

Trials (filtered) newest first · largest first

All 54 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Propranolol, Psychotherapy - Post-Traumatic Stress Disorder, PTSD
Phase 3Not yet recruitingUniversity Hospital, Toulouse702026-12-012026-11-06
Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study
Propranolol + Placebo - Traumatic Brain Injury (TBI) Patients
Phase 3RecruitingFundació d'investigació Sanitària de les Illes Balears5362026-06-012026-10-27
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
propranolol, normal saline IV - Traumatic Brain Injury (TBI) Patients, Intracranial Pressure
Phase 3Not yet recruitingTanta University602025-09-202025-03-11
Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine
Propranolol 80 mg, Magnesium 400Mg - Migraine, Nutraceuticals
Phase 3Not yet recruitingFayoum University1002025-08-202025-08-29
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3Active not recruitingWest China Hospital342025-02-012026-11-16
Zonisamide Versus Propranolol in Migraine
Zonisamide 50 MG, Propranolol - Migraine
Phase 3UnknownKafrelsheikh University6002024-03-292024-04-23
PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)
Propranolol Hydrochloride, control group - Stroke, Vascular Accident
Phase 2 / Phase 3CompletedBeijing Tiantan Hospital1682023-02-212025-07-14
Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol
Propranolol Oral Product, Placebo, memory reactivation - PTSD
Phase 3RecruitingUniversity Hospital, Toulouse922023-02-012023-08-28
Role of Combined Therapy of Propranolol and Gabapentin in Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury
Propranolol , gabapentin - Traumatic Brain Injury
Phase 3UnknownZagazig University902022-12-012023-06-13
Lacosamide Versus Propranolol in Migraine
Lacosamide tablet, Propranolol - Migraine Disorders
Phase 3CompletedKafrelsheikh University6002022-06-012024-05-01
Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation
Propranolol Hydrochloride - Mechanical Ventilation, Sedation
Phase 3CompletedOttawa Hospital Research Institute722021-01-082022-12-05
Propranolol Rescue of Prolonged Labor
Propranolol Hydrochloride, Saline - Pregnancy, Prolonged
Phase 3TerminatedLisa Levine1642020-07-142023-08-23
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
Propranolol, Carvedilol, Rosuvastatin - Cirrhosis, Portal Hypertension
Phase 2 / Phase 3UnknownUniversidade Federal do Rio de Janeiro802019-01-252019-05-14
Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial
Combined Intravitreal bevacizumab and propranolol, Intravitreal bevacizumab - Age Related Macular Degeneration
Phase 2 / Phase 3UnknownShahid Beheshti University of Medical Sciences402018-09-012018-08-01
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
nonselective beta blocker, cardio-selective beta blocker group, alendronate sodium - Beta Blocker Toxicity
Phase 3RecruitingSherief Abd-Elsalam502017-10-012021-01-12
Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
Propranolol Hydrochloride, Placebo Oral Tablet - Tardive Dyskinesia
Phase 2 / Phase 3WithdrawnEmory University2017-09-182019-02-26
MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Propranolol, Placebo - Melanoma
Phase 2 / Phase 3UnknownAzienda Sanitaria di Firenze5462017-06-012016-11-15
Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism
Cholestyramine Powder 4g, Prednisolone, Standard treatment - Hyperthyroidism, Graves Disease
Phase 3UnknownClinical Research Centre, Malaysia1352017-05-112017-10-05
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
oral propranolol, oral atenolol - Infantile Hemangioma
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh602017-03-242018-08-28
Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
Proton-pump inhibitor, Propranolol+Proton-pump inhibitor - Liver Cirrhosis, Peptic Ulcer
Phase 2 / Phase 3TerminatedTaipei Veterans General Hospital, Taiwan102016-12-262020-06-23

Showing 20 of 54. Sign in to see all of them.

Conditions studied

Burns (5)  ·  Hemangioma, Capillary (5)  ·  Hypertension, Portal (5)  ·  Liver Cirrhosis (5)  ·  Fibrosis (4)  ·  Migraine Disorders (4)  ·  Stress Disorders, Post-Traumatic (4)  ·  Brain Injuries, Traumatic (3)  ·  Hemangioma (3)  ·  Cardiovascular Diseases (2)  ·  Coronary Disease (2)  ·  Esophageal and Gastric Varices (2)  ·  Heart Diseases (2)  ·  Migraine with Aura (2)  ·  Migraine without Aura (2)

Sponsors

The University of Texas Medical Branch, Galveston (5)  ·  Govind Ballabh Pant Hospital (2)  ·  Kafrelsheikh University (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  University Hospital, Toulouse (2)  ·  West China Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Ain Shams Maternity Hospital (1)  ·  Anne Lindblad (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda Sanitaria di Firenze (1)  ·  Beijing Tiantan Hospital (1)  ·  Clinical Research Centre, Malaysia (1)  ·  Douglas Mental Health University Institute (1)

Countries

United States (12)  ·  Canada (6)  ·  Egypt (6)  ·  France (5)  ·  China (4)  ·  India (4)  ·  Italy (3)  ·  Germany (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Denmark (1)

Top investigators

David N Herndon, MD (4)  ·  A. Eden Evins, MD, MPH (1)  ·  Allan Barker (1)  ·  Allan Jaffee (1)  ·  Charles Laubach (1)  ·  Charles-Siegfried Peretti, MD, PhD (1)  ·  Christine B Sethna, MD, EdM (1)  ·  Christine Labreze, MD (1)  ·  Christopher Hartnick, MD (1)  ·  David Dodick, MD (1)  ·  David N. Herndon, MD (1)  ·  David Richardson (1)  ·  Davide D'Amico, prof, MD (1)

Results publications

PMID 11914403, PMID 12807523, PMID 22606232, PMID 15316798, PMID 18791359, PMID 19240154, PMID 19734776, PMID 20395554, PMID 20547163, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22401315, PMID 22463890, PMID 22895351, PMID 22962431, PMID 23031335, PMID 23150682, PMID 23303450, PMID 23511841, PMID 24009246, PMID 24050955, PMID 24054431, PMID 24298851, PMID 24335848, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25514427, PMID 25693013, PMID 25807408, PMID 26607848, PMID 27171844, PMID 27433905, PMID 28240622, PMID 33856430, PMID 34747977, PMID 35672572, PMID 36031005, PMID 36656551, PMID 37290102, PMID 38767196, PMID 39082471, PMID 39982178, PMID 41863672, PMID 42088573, PMID 42104241, PMID 8984084

NIH funding

2008 (2), 2025 (2), P50GM060338 (2), R01GM056687 (1)